These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1579959)

  • 1. Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset.
    Haley EC; Levy DE; Brott TG; Sheppard GL; Wong MC; Kongable GL; Torner JC; Marler JR
    Stroke; 1992 May; 23(5):641-5. PubMed ID: 1579959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes.
    Brott TG; Haley EC; Levy DE; Barsan W; Broderick J; Sheppard GL; Spilker J; Kongable GL; Massey S; Reed R
    Stroke; 1992 May; 23(5):632-40. PubMed ID: 1579958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue plasminogen activator for acute ischemic stroke.
    National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
    N Engl J Med; 1995 Dec; 333(24):1581-7. PubMed ID: 7477192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group.
    Haley EC; Brott TG; Sheppard GL; Barsan W; Broderick J; Marler JR; Kongable GL; Spilker J; Massey S; Hansen CA
    Stroke; 1993 Jul; 24(7):1000-4. PubMed ID: 8322373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke.
    von Kummer R; Hacke W
    Stroke; 1992 May; 23(5):646-52. PubMed ID: 1579960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group.
    Stroke; 1997 Nov; 28(11):2109-18. PubMed ID: 9368550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice.
    Chiu D; Krieger D; Villar-Cordova C; Kasner SE; Morgenstern LB; Bratina PL; Yatsu FM; Grotta JC
    Stroke; 1998 Jan; 29(1):18-22. PubMed ID: 9445322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
    Ong CT; Wong YS; Wu CS; Su YH
    Drug Des Devel Ther; 2017; 11():1559-1566. PubMed ID: 28572721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000.
    Grotta JC; Burgin WS; El-Mitwalli A; Long M; Campbell M; Morgenstern LB; Malkoff M; Alexandrov AV
    Arch Neurol; 2001 Dec; 58(12):2009-13. PubMed ID: 11735774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.
    Albers GW; Bates VE; Clark WM; Bell R; Verro P; Hamilton SA
    JAMA; 2000 Mar; 283(9):1145-50. PubMed ID: 10703776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot dose-escalation study of caffeine plus ethanol (caffeinol) in acute ischemic stroke.
    Piriyawat P; Labiche LA; Burgin WS; Aronowski JA; Grotta JC
    Stroke; 2003 May; 34(5):1242-5. PubMed ID: 12690224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke.
    Haley EC; Lyden PD; Johnston KC; Hemmen TM;
    Stroke; 2005 Mar; 36(3):607-12. PubMed ID: 15692126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.
    del Zoppo GJ; Higashida RT; Furlan AJ; Pessin MS; Rowley HA; Gent M
    Stroke; 1998 Jan; 29(1):4-11. PubMed ID: 9445320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of a new thrombolytic agent for acute ischemic stroke in Taiwan within a five-hour window.
    Hu HH; Teng MM; Hsu LC; Wong WJ; Wang LM; Luk YO; Chern CM; Soong BW; Sheng WY
    Stroke; 2006 Mar; 37(3):918-9. PubMed ID: 16424373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-tissue plasminogen activator blood pressure levels and risk of symptomatic intracerebral hemorrhage.
    Tsivgoulis G; Frey JL; Flaster M; Sharma VK; Lao AY; Hoover SL; Liu W; Stamboulis E; Alexandrov AW; Malkoff MD; Alexandrov AV
    Stroke; 2009 Nov; 40(11):3631-4. PubMed ID: 19762689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperacute stroke therapy with tissue plasminogen activator.
    Alberts MJ
    Am J Cardiol; 1997 Aug; 80(4C):29D-34D; discussion 35D-39D. PubMed ID: 9284041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolytic therapy in cerebrovascular disorders.
    Levine SR; Brott TG
    Prog Cardiovasc Dis; 1992; 34(4):235-62. PubMed ID: 1728786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.